6Lee AW,Poor VF,Foo W et al.Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985:overall survival and patterns of failure.Int J Radiat Oncol Biol Phys,1992,2:261
4Zhang L, Yu D, Hu M, et al. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res, 2000,60:3655-3661.
5Zhang EP, Lian PG, Cai KL,et al. Radiation therapy of nasopharyngeal carcinoma: prognostic factors based on a 10-year follow-up of 1302 patients. Int J Radiat Oncol Biol Phys, 1989,16:301-305.
6Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys, 1992,23:261-270.
7Kanegae Y, Makimura M,Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol, 1994,47:157-166.
8Brand K, Klocke R, Possling A, et al. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Ther, 1999, 6: 1054-1063.
9Li JH, Lax SA, Kim J, et al. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 1999, 43:607-616.
10Clayman GL, el-Naggar AK, Lippman SM, et al. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol, 1998,16:2221-2232.
